The estimated Net Worth of Joseph W La Plume is at least 17.3 百万$ dollars as of 8 August 2024. Mr. Plume owns over 1,780 units of Charles River Laboratories International stock worth over 4,359,840$ and over the last 6 years he sold CRL stock worth over 9,975,078$. In addition, he makes 3,009,510$ as Corporate Executive Vice President、 Corporate Development and Strategy at Charles River Laboratories International.
Joseph has made over 20 trades of the Charles River Laboratories International stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,780 units of CRL stock worth 354,861$ on 8 August 2024.
The largest trade he's ever made was selling 15,768 units of Charles River Laboratories International stock on 15 May 2020 worth over 2,655,331$. On average, Joseph trades about 1,950 units every 48 days since 2019. As of 8 August 2024 he still owns at least 22,521 units of Charles River Laboratories International stock.
You can see the complete history of Mr. Plume stock trades at the bottom of the page.
Joseph W. LaPlume serves as Corporate Executive Vice President, Corporate Development and Strategy of the Company. He joined us in 2005 as Senior Corporate Counsel. He became Deputy General Counsel in 2010, Vice President, Corporate Development in 2011, Senior Vice President in 2014 and Corporate Executive Vice President, Corporate Development and Strategy in January 2019. In his current role, he oversees all aspects of strategic planning and corporate development activities across business segments and geographies. Prior to joining us, Mr. LaPlume was a corporate lawyer at GTECH Corporation and in private practice at the law firms of Mintz Levin and Goulston & Storrs.
As the Corporate Executive Vice President、 Corporate Development and Strategy of Charles River Laboratories International, the total compensation of Joseph LaPlume at Charles River Laboratories International is 3,009,510$. There are 3 executives at Charles River Laboratories International getting paid more, with James Foster having the highest compensation of 17,722,100$.
Joseph LaPlume is 46, he's been the Corporate Executive Vice President、 Corporate Development and Strategy of Charles River Laboratories International since 2019. There are 20 older and 1 younger executives at Charles River Laboratories International. The oldest executive at Charles River Laboratories International Inc. is Stephen Chubb, 76, who is the Independent Director.
Over the last 22 years, insiders at Charles River Laboratories International have traded over 220,588,205$ worth of Charles River Laboratories International stock and bought 18,392 units worth 3,841,397$ . The most active insiders traders include James C Foster、Richard F Wallman、David P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of 2,223,188$. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth 354,861$.
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
Charles River Laboratories International executives and other stock owners filed with the SEC include: